Pharmaxis
(ASX:PXS)

Health & Biotech

These are the 22 small cap biotechs closest to bringing a drug to market

November 3, 2019January 15, 2024 | Daniel Paproth

Health & Biotech

Health: Resonance Health says cash receipts continue to grow, but investors are looking for more

October 28, 2019December 18, 2023 | Sam Jacobs

Health & Biotech

Health: Good news from the US sends Novita shares up +60%

October 24, 2019December 18, 2023 | Sam Jacobs

News

Weekly small cap wrap: Who entertained a big purchase?

August 16, 2019December 18, 2023 | Reuben Adams

Health & Biotech

Health: Pharmaxis tumbles way into the red as fortunes fluctuate on handballed drug

August 15, 2019December 18, 2023 | Daniel Paproth

Health & Biotech

Dr Boreham’s Crucible: Pharmaxis shareholders breathe easy – the FDA loves you

July 22, 2019December 18, 2023 | Tim Boreham

Health & Biotech

Health: Pharmaxis on verge of $14.3m payout after FDA close call on Bronchitol

May 9, 2019December 18, 2023 | Daniel Paproth

Health & Biotech

Fatty liver disease drug maker Pharmaxis adds pancreatic cancer to lineup

February 22, 2019December 18, 2023 | Daniel Paproth

Health & Biotech

Pharmaxis just posted a $12.6m half-year loss, but it’s not as bad as it looks

February 15, 2019December 18, 2023 | Daniel Paproth

Health & Biotech

Resonance Health just went from wallflower to overnight wonder: here’s why

January 16, 2019December 18, 2023 | Rachel Williamson

Health & Biotech

Pharmaxis says Big Pharma can’t wait to get a cut of its drugs

November 15, 2018December 18, 2023 | Daniel Paproth

Health & Biotech

Pharmaxis gets another fatty liver drug through clinical trials; shares gain

October 11, 2018December 18, 2023 | Rachel Williamson

Health & Biotech

Drug developer Pharmaxis turns loss into $6m profit

August 17, 2018December 18, 2023 | Daniel Paproth

Health & Biotech

What biotech success looks like: a $15m payout when someone else trials your drug

January 11, 2018December 18, 2023 | Rachel Williamson